I agree that there is still hope but....that hope, however, rests on the efficacy of the peptides that Generex is evaluating. I believed, incorrectly as it turns out, that the peptide evaluation process had begun in early June and would conclude in a month or two. The PR about the July 10 CC implied that the peptide evaluation had not yet begun. As sincere as joe may be, I don’t anticipate that Generex will get a cent from either BARDA or CEPI until they can demonstrate that one or more of the peptides actually work. Heaven only knows when that might occur. But there is hope.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links